Abstract: The invention includes methods and kits that can be used to simultaneously determine whether an antibody out of a plurality of antibodies is present in a sample. In certain embodiments, at least one of the antibodies comprises an autoantibody. In other embodiments, the methods and kits of the invention can be used to simultaneously determine if a subject is likely to develop or has developed each one of a plurality of diseases or disorders.

Abstract: Methods for inhibiting an autoimmune disease by administering to a subject a therapeutically effective amount of a composition that induces conversion of naive T cells into Foxp3+ regulatory T cells to induce immunosuppression in the subject. Methods for detecting in a subject an autoimmune disease or a predisposition to an autoimmune disease, and methods for assessing the efficacy of a therapy for an autoimmune disease, particularly type 1 diabetes.

Abstract: Methods of preventing, treating or ameliorating autoimmune diabetes by modulating the binding of MHC class II molecules to antigenic peptides or fragments of antigenic peptides of the autoimmune disease by the administration of methyldopa. Pharmaceutical compositions containing therapeutically effective amounts of methyldopa in extended release formulations and methods of using the same are also provided.

Abstract: Embodiments herein concern compositions and methods for treating diabetes in a subject.

Abstract: Embodiments herein concern compositions and methods for treating diabetes in a subject.